1. 球脊髄性筋萎縮症 Spinal and bulbar muscular atrophy Clinical trials / Disease details

臨床試験数 : 17 / 薬物数 : 16 - (DrugBank : 8) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 17

7 trials found

diseases per page:

Showing 1 to 7 of 7 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03555578 (ClinicalTrials.gov)	November 2, 2017	1/6/2018	Specified Drug-Use Survey of Leuprorelin AcetateInjection Kit 11.25 mg All-Case Investigation: Spina ...	Specified Drug-Use Survey of Leuprorelin AcetateInjection Kit 11.25 mg All-Case Investigation: Spina ...	Spinal and Bulbar Muscular Atrophy	Drug: Leuprorelin Acetate	Takeda	NULL	Recruiting	N/A	N/A	All	300		Japan
2	JPRN-JapicCTI-183981	02/11/2017	01/06/2018	Specified Drug-Use Survey of Leuprorelin AcetateInjection Kit 11.25 mg All-Case Investigation: Spina ...	Specified Drug-Use Survey of Leuprorelin AcetateInjection Kit 11.25 mg All-Case Investigation: Spina ...	Spinal and bulbar muscular atrophy	Intervention name : Leuprorelin Acetate Dosage And administration of the intervention : Leuprorelin Ace ...	TAKEDA PHARMACEUTICAL COMPANY LTD.	NULL	recruiting			BOTH	300	NA	NULL
3	JPRN-JMA-IIA00080	02/2012	26/01/2012	Phase 2 Clinical Trial of Leuprorelin acetate in patients with SBMA (JASMITT-2)	Double-blind Placebo-controlled Phase 2 Clinical Trial of TAP-144-SR (3M) in patients with Spinal an ...	Spinal and Bulbar muscular atrophy	Intervention type:DRUG. Intervention1:TAP-144-SR(3M), Dose form:INJECTION, Route of administration:S ...	JASMITT Clinical Trial Office	Jichi med college, Chiba univ., Univ of Tokyo, Tokyo med & dental univ.	Completed	>=30 YEARS	<70 YEARS	Male	100	Phase 2	Japan
4	JPRN-UMIN000001455	2008/10/01	23/10/2008	Open clinical trial of Leuprorelin Acetate (SR) in patients with Kennedy-Alter-Sung syndrome (KAS)		Kennedy-Alter-Sung syndrome (KAS)	Leuprorelin acetate (SR) 11.25mg subcutaneous infection per 12 weeks	Department of NeurologyChiba University Graduate School of Medicine	NULL		20years-old	Not applicable	Male	10	Not selected	Japan
5	JPRN-JMA-IIA00111	29/08/2007	22/02/2013	Long Term Follow-up Phase III Clinical Trial of Leuprorelin acetate in Patients with SBMA (JASMITT)	Long Term Follow-up Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal and Bulbar M ...	Spinal and Bulbar Muscular Atrophy (SBMA)	Intervention type:DRUG. Intervention1:TAP-144-SR(3M), Dose form:INJECTION, Route of administration:S ...	Gen Sobue	Ichiro Yabe, Masashi Aoki, Imaharu Nakano, Kazuaki Kanai, Hidehiro Mizusawa, Tomotaka Yamamoto, Kazu ...	Completed	>=30 YEARS	<71 YEARS	Male	152	Phase 3	Japan
6	JPRN-JMA-IIA00009	13/09/2006	24/08/2006	Phase III Clinical Trial of Leuprorelin acetate in Patients with SBMA (JASMITT)	Double-blind Placebo-controlled Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal ...	Spinal and Bulbar Muscular Atrophy (SBMA)	Intervention type:DRUG. Intervention1:TAP-144-SR(3M), Dose form:INJECTION, Route of administration:S ...	JASMITT Clinical Trial Office	Hokkaido University, Tohoku University, Jichi Medical College, Chiba University, University of Tokyo ...	Completed	>=30 YEARS	<70 YEARS	Male	170	Phase 3	Japan
7	JPRN-UMIN000000474	2003/09/01	01/09/2006	Double-blind Placebo-controlled Clinical Trial of Leuprorelin acetatein Patients with Spinal and Bul ...		Spinal and bulbar muscular atrophy (SBMA)	Leuprorelin acetate3.75 mg subcutaneous injection every 4 weeks Placebo subcutaneous injection every ...	Department of Neurology, Nagoya University School of Medicine	NULL	Complete: follow-up complete	30years-old	70years-old	Male	40	Phase 2	Japan

First Previous1Next Last